(Hypertension. 1999;34:897-901.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Biophysics, Escola Paulista de Medicina, São Paulo, Brazil.
Correspondence to Therezinha B. Paiva, Department of Biophysics, Escola Paulista de Medicina, Rua Botucatu 862, 04023-062 São Paulo SP, Brazil. E-mail tbpaiva{at}biofis.EPM.BR
AbstractWe studied the effect
of oral cholecalciferol treatment on the
endothelium-dependent vascular relaxation and
hyperpolarization induced by acetylcholine (ACh),
which is impaired in spontaneously hypertensive rats (SHR).
Adult female SHR and normotensive Wistar-Kyoto rat (WKY) controls
received 125 µg of cholecalciferol per kilogram body weight per day
for 6 weeks. The responses to ACh of the isolated mesenteric vascular
bed and mesenteric artery rings were measured, as well as the smooth
muscle cell membrane potential. After cholecalciferol treatment, the
systolic blood pressure and basal perfusion pressure of the
mesenteric vascular bed of the SHR fell to control levels. The relaxant
and hyperpolarizing effects of ACh, which are reduced in SHR, were also
brought to control levels after cholecalciferol treatment. These
effects of ACh were inhibited by
N
-nitro-L-arginine in
SHR and by apamin in WKY. After cholecalciferol treatment, SHR
hyperpolarizing responses showed the same inhibition pattern as those
of WKY. This indicates that, after cholecalciferol treatment, SHR
vascular mesenteric preparation responses to ACh are mediated by
endothelium-derived hyperpolarizing factor, which
induces activation of Ca2+-dependent K+
channels, as in WKY. In untreated SHR, the ACh-mediated response is
entirely due to ACh acting via the release of nitric oxide.
Key Words: rats, inbred SHR arteries membranes potassium acetylcholine cholecalciferol
This article has been cited by other articles:
![]() |
G. M. London, A. P. Guerin, F. H. Verbeke, B. Pannier, P. Boutouyrie, S. J. Marchais, and F. Metivier Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency J. Am. Soc. Nephrol., February 1, 2007; 18(2): 613 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Forman, H. A. Bischoff-Ferrari, W. C. Willett, M. J. Stampfer, and G. C. Curhan Vitamin D Intake and Risk of Incident Hypertension: Results From Three Large Prospective Cohort Studies Hypertension, October 1, 2005; 46(4): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Sobey Potassium Channel Function in Vascular Disease Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 28 - 38. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |